Pericarditis Treatment Titration
Start with aspirin 750-1000 mg every 8 hours or ibuprofen 600 mg every 8 hours plus weight-adjusted colchicine (0.5 mg once daily if <70 kg, 0.5 mg twice daily if ≥70 kg) for at least 3 months, tapering NSAIDs/aspirin gradually only after symptoms resolve and CRP normalizes. 1
First-Line Therapy: NSAIDs/Aspirin + Colchicine
Initial Dosing
- Aspirin: 500-1000 mg every 6-8 hours (total daily dose 1.5-4 g/day) 2
- Ibuprofen: 600 mg every 8 hours (total daily dose 1200-2400 mg) 2
- Indomethacin: 25-50 mg every 8 hours, starting at the lower end to avoid headache and dizziness 2
- Colchicine: 0.5 mg once daily if body weight <70 kg OR 0.5 mg twice daily if ≥70 kg, without a loading dose 2, 1
Treatment Duration
- NSAIDs/aspirin should be continued for weeks to months, guided by symptom resolution and CRP normalization 2, 1
- Colchicine must be continued for at least 3-6 months for initial episodes 1, 3
- For first recurrence, extend colchicine to at least 6 months 4
Tapering NSAIDs/Aspirin
Critical principle: Only attempt tapering when symptoms are completely absent and CRP is normal 2
- Aspirin: Decrease by 250-500 mg every 1-2 weeks 2
- Ibuprofen: Decrease by 200-400 mg every 1-2 weeks 2
- Indomethacin: Decrease by 25 mg every 1-2 weeks 2
- Longer tapering periods (extending to several months) should be used for difficult, resistant cases 2
Tapering Colchicine
- Colchicine tapering is not necessary in most cases 2
- Alternative approach for patients <70 kg: reduce to 0.5 mg every other day before discontinuation 2
- After obtaining complete response, taper one drug class at a time before gradually discontinuing colchicine over several months in difficult cases 2
Second-Line Therapy: Corticosteroids
When to Use Corticosteroids
Corticosteroids should be added to, not replace NSAIDs/aspirin and colchicine as triple therapy in these specific situations: 2
- Incomplete response to aspirin/NSAIDs and colchicine
- Specific indications: systemic inflammatory diseases, post-pericardiotomy syndrome, pregnancy 2
- True NSAID allergy, recent peptic ulcer/GI bleeding, high bleeding risk with anticoagulation 2
- NSAID intolerance or persistent disease despite appropriate doses 2
Critical caveat: Corticosteroids provide rapid symptom control but promote chronicity, increase recurrence rates, and cause more side effects 2, 1
Corticosteroid Dosing
- Initial dose: Prednisone 0.2-0.5 mg/kg/day (low to moderate doses) 2, 1
- Never use corticosteroids as first-line therapy 1, 3
Corticosteroid Tapering Algorithm
This is the most critical aspect—tapering must be extremely slow: 2
| Current Prednisone Dose | Tapering Schedule |
|---|---|
| >50 mg/day | Decrease by 10 mg every 1-2 weeks [2] |
| 50-25 mg/day | Decrease by 5-10 mg every 1-2 weeks [2] |
| 25-15 mg/day | Decrease by 2.5-5 mg every 2-4 weeks [2] |
| 15-10 mg/day (CRITICAL THRESHOLD) | Decrease by 1.0-2.5 mg every 2-6 weeks [2] |
| <10 mg/day | Decrease by 1.0-2.5 mg every 2-6 weeks [2] |
The 10-15 mg/day threshold is where most recurrences occur—use extremely small decrements at this point 2
Sequential Tapering Strategy
When achieving complete response, follow this order: 2
- Taper one drug class at a time
- Complete NSAID/aspirin taper first
- Then taper corticosteroids (if used) using the slow schedule above
- Finally discontinue colchicine last, over several months in difficult cases
Each tapering attempt should only occur when symptoms are absent and CRP is normal 2
Common Pitfalls to Avoid
- Inadequate treatment of first episode is the most common cause of recurrence 1
- Never increase corticosteroid dose or reinstate steroids if recurrence occurs—instead, optimize NSAIDs and colchicine 2
- Avoid rapid tapering (within 1 month)—this significantly increases recurrence risk 3
- Do not taper multiple drugs simultaneously—taper one class at a time 2
- Corticosteroids at high doses are associated with higher recurrence rates—use low to moderate doses only 2, 5
- Recurrence rates increase from 15-30% without colchicine to 50% after first recurrence 1
Monitoring During Tapering
- Use CRP levels to guide treatment length and assess response 1, 6
- Symptoms must be completely absent before attempting any dose reduction 2
- Recurrences are possible after discontinuation of each drug 2
- If recurrence occurs during tapering, return to the previous effective dose and maintain longer before attempting slower taper 2